KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardelyx (ARDX) Research & Development (2016 - 2025)

Ardelyx's Research & Development history spans 13 years, with the latest figure at $22.9 million for Q4 2025.

  • For Q4 2025, Research & Development rose 67.25% year-over-year to $22.9 million; the TTM value through Dec 2025 reached $71.5 million, up 36.72%, while the annual FY2025 figure was $71.5 million, 36.72% up from the prior year.
  • Research & Development reached $22.9 million in Q4 2025 per ARDX's latest filing, up from $18.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $26.0 million in Q2 2021 to a low of $7.5 million in Q3 2022.
  • Average Research & Development over 5 years is $14.3 million, with a median of $13.2 million recorded in 2024.
  • Peak YoY movement for Research & Development: soared 93.59% in 2021, then tumbled 68.49% in 2022.
  • A 5-year view of Research & Development shows it stood at $21.0 million in 2021, then crashed by 56.4% to $9.1 million in 2022, then increased by 4.18% to $9.5 million in 2023, then surged by 43.49% to $13.7 million in 2024, then soared by 67.25% to $22.9 million in 2025.
  • Per Business Quant, the three most recent readings for ARDX's Research & Development are $22.9 million (Q4 2025), $18.1 million (Q3 2025), and $15.7 million (Q2 2025).